$1.09 -0.02 (%) Rosetta Genomics Ltd - NASDAQ

Jul. 22, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Rosetta Genomics Reports Advancement of Collaboration with Biocept for PoC Studies Aimed at microRNA Profiling of Circulating Tumor Cells

    Benzinga | Dec. 14, 2015 | 08:13AM EST
  2. Rosetta Provides Update on Performance Data and Launch of RosettaGX Revealâ„¢ (Thyroid microRNA Classifier)

    Benzinga | Nov. 12, 2015 | 08:58AM EST
  3. Rosetta Genomics to Host Business Update, Six Month Financials Conference Call on October 27, 2015

    Benzinga | Oct. 20, 2015 | 08:33AM EST
  4. Rosetta Genomics Launches BRAF Mutation Assay

    Benzinga | Oct. 12, 2015 | 08:32AM EST
  5. Rosetta Genomics Announces Agreement with MultiPlan for its PersonalizeDx Suite of Testing Services

    Benzinga | Jun. 16, 2015 | 08:31AM EST
  6. Rosetta Genomics Launches Two Assays for Bladder Cancer

    Benzinga | May. 14, 2015 | 08:50AM EST
  7. Benzinga's Top Initiations

    Benzinga | Apr. 30, 2015 | 09:40AM EST
  8. Benzinga's Top Upgrades

    Benzinga | Apr. 17, 2015 | 08:57AM EST
  9. Morning Market Gainers

    Benzinga | Feb. 17, 2015 | 09:43AM EST
  10. Rosetta Genomics and Marina Biotech Initiate First Clinical Project Under Strategic Alliance

    GuruFocus | Nov. 18, 2014 | 11:04AM EST
  11. Rosetta Genomics' microRNA-Based Assay For Thyroid Cancer Highlighted In Poster Presentation At 84th Annual Meeting Of The American Thyroid Association

    Benzinga | Oct. 23, 2014 | 08:06AM EST
  12. Biocept And Rosetta Genomics Collaborate To Evaluate microRNAs From Circulating Tumor Cells

    Benzinga | Oct. 13, 2014 | 08:31AM EST
  13. Rosetta Genomics Announces Final New York State Approval for Rosetta Kidney Cancer Test

    Benzinga | Jul. 22, 2014 | 09:33AM EST
  14. UPDATE: Barrington Research Initiates Coverage On Rosetta Genomics Ltd. On Good Market Position

    Benzinga | Jun. 4, 2014 | 10:33AM EST
  15. Morning Market Movers

    Benzinga | Jan. 13, 2014 | 09:54AM EST
  16. Rosetta Genomics Reports Execution of Credentialing Deals with Two National Healthcare Preferred Provider Networks

    Benzinga | Sep. 9, 2013 | 08:36AM EST
  17. Rosetta Genomics Wins Two Key US Patent Allowances

    Benzinga | Feb. 14, 2013 | 01:35AM EST
  18. Rosetta Genomics Expands Management Team With CMO and CSO

    Benzinga | Oct. 11, 2012 | 03:48AM EST
  19. Benzinga's M&A Chatter for Thursday October 4, 2012

    Benzinga | Oct. 4, 2012 | 12:13PM EST
  20. Rosetta Genomics (ROSG) Up 5.5% After Announcing Business Update

    MarketIntelligenceCenter | Sep. 18, 2012 | 11:44AM EST
  21. Health Care Sector Wrap

    FoxBusiness | Aug. 29, 2012 | 10:45AM EST
  22. Rosetta Genomics Announces Exercise and Closing of Underwriter's Over-Allotment Option

    Benzinga | Aug. 29, 2012 | 06:04AM EST
  23. A Peek Into The Market Before The Trading Starts

    Benzinga | Aug. 3, 2012 | 01:15AM EST
  24. Rosetta Genomics Announces Pricing of Public Offering of 5.5 Million Ordinary Shares at $5/Share

    Benzinga | Aug. 3, 2012 | 00:46AM EST
  25. Six Flags Entertainment, Sanmina-SCI Corporation Among Stocks Gapping Up Tuesday

    FoxBusiness | Jul. 24, 2012 | 04:31AM EST
  26. Health Care Sector Wrap

    FoxBusiness | Jul. 10, 2012 | 10:47AM EST
  27. Rosetta Genomics (ROSG) Up 7.7% After NY Approval for Lung Cancer Test, Stock Sale

    MarketIntelligenceCenter | Jun. 26, 2012 | 13:33PM EST
  28. Rosetta Genomics Secures Reimbursement Pricing, Shares Surge 15%

    Benzinga | Jun. 19, 2012 | 04:16AM EST
  29. Rosetta Genomics Announces Compliance With Continued Listing Requirements of The NASDAQ Capital Market

    Benzinga | Jun. 6, 2012 | 01:32AM EST
  30. Genetic Technologies Executes Exclusive Distribution Agreement with Rosetta Genomics

    Benzinga | Jun. 1, 2012 | 07:04AM EST
  31. Data on Two of Rosetta Genomics' Launched Diagnostic Assays to Be Presented at ASCO 2012

    Benzinga | Jun. 1, 2012 | 02:18AM EST
  32. Rosetta Genomics Announces Study Validating miRview mets2 Published in The Oncologist

    Benzinga | May. 25, 2012 | 04:29AM EST
  33. From Earlier: Rosetta Genomics to Raise $6.6M in Registered Direct Offering

    Benzinga | May. 25, 2012 | 01:17AM EST
  34. Benzinga's Microcap Movers for Thursday May 24, 2012

    Benzinga | May. 25, 2012 | 01:13AM EST
  35. Rosetta Genomics (ROSG) Gains 124.2% as Runup Continues

    MarketIntelligenceCenter | May. 24, 2012 | 12:58PM EST
  36. Rosetta Genomics Surges, Shares Rise 1000% in 8 Trading Days

    Benzinga | May. 24, 2012 | 06:19AM EST
  37. From Earlier: Rosetta Genomics to Raise $2.2 Million in Registered Direct Offering

    Benzinga | May. 17, 2012 | 01:24AM EST
  38. Rosetta Genomics Announces One-for-Fifteen Reverse Stock Split

    Benzinga | May. 14, 2012 | 05:53AM EST
  39. Rosetta Announces $1.75 Million Debt Financing and Potential $1.25 Million Licensing Transaction

    Benzinga | Jan. 27, 2012 | 01:46AM EST
  40. Benzinga's Microcap Movers for Wednesday January 25, 2012

    Benzinga | Jan. 25, 2012 | 16:41PM EST
Trading Center